Okolie Fails VADA Test — Paris Card Cancelled Five Days Out

• Lawrence Okolie returned an adverse VADA finding for GHRP-2, a growth hormone secretagogue. Queensberry informed of the result on Tuesday morning.
• Saturday's Adidas Arena card in Paris — Yoka vs Okolie plus the full undercard — has been fully cancelled by Queensberry.
• Okolie blames elbow-injury treatment during camp; he faces a potential four-year ban unless he can prove no fault.

Right Then — The Facts, Cold

Right then, let's not beat around the bush. Lawrence Okolie has failed a VADA test. The Voluntary Anti-Doping Association informed Queensberry overnight, the news broke Tuesday morning, and the show in Paris is gone. Not postponed. Cancelled. Okolie vs Tony Yoka is dead. Bakary Samake's co-main is gone. Solis is gone. Every undercard fighter who trained for April 25 in the Adidas Arena has had their night pulled out from under them. The substance is GHRP-2 — a growth hormone releasing peptide. Not a maybe, not a trace element people argue about in a lab for six months. GHRP-2 is a secretagogue, which is the sort of word people use to make a banned substance sound medical. What it actually does is tell your pituitary to pump out more growth hormone. Recovery. Muscle. Fat loss. Every single benefit you'd want in a fight camp. It is on the WADA prohibited list at all times, in and out of competition.

Queensberry's Statement — And The Cancellation

Frank Warren's team put it cleanly in their statement: "Last night, the Voluntary Anti-Doping Association (VADA) informed Queensberry that Lawrence Okolie returned an adverse finding following an anti-doping test conducted ahead of the show in Paris this Saturday." The event at the Adidas Arena is off. Full stop. Make no mistake about how big a call that is. They tried to save it. There were noises about David Adeleye stepping in for Yoka. For a few hours on Tuesday it felt like there was a route to keep at least the main event alive. Ten hours after the news broke, Queensberry pulled the whole card. That tells you the scale of what's happened behind closed doors. You don't pull a card at the Adidas Arena with paid punters, French broadcast commitments and a Saudi backer watching unless the alternative is worse.

Okolie's Explanation — And Why It Matters Less Than You Think

Okolie's statement is worth reading in full because it's the template every fighter uses when a test comes back funny. "Following my bicep injury last year, I sustained an elbow injury on the same arm during this camp. I had a treatment on it and now we are here." He's confident any investigation will clear his name. He's pledged to cooperate. Look, here's the deal. Fighters do get injured in camp. Elbow treatment does sometimes involve things that sit near the line. But GHRP-2 is not a topical cream. It's not an anti-inflammatory. It's an injectable peptide that tells your body to make growth hormone. If a doctor prescribed that for an elbow problem without a TUE, that doctor is wrong. If no doctor prescribed it and it got into his body anyway, that's a different conversation, and it's not one Okolie's PR team are going to win quickly. The ban tariff under the ADRV code is up to four years. There's a route back — significant mitigation, contaminated supplement defence, no-fault finding — but those are uphill arguments and they take months. This isn't a story where Okolie is back in the ring in June.

What It Does To Okolie's Career

Let's not sit on the fence. Okolie was the WBC's number one heavyweight contender, three wins into his run at the real weight, finally looking like the fighter the hype said he'd be after Sunny Edwards and the cruiserweight exodus. Saturday was meant to be the proper test — Yoka in front of a hostile French crowd, for the WBC Silver and mandatory positioning. One win and Okolie's in the conversation with Wardley, Dubois and Kabayel for actual world-title business later in the year. That's all gone. Even if he gets the shortest possible sanction — say, a contaminated-supplement finding with a six-month ban — he's out of the rankings conversation for the rest of 2026. His name was attached to the winner-clause on Hrgovic vs Allen on May 16. That's almost certainly off the table now. Wardley-Dubois on May 9 goes ahead without Okolie in the background as a credible next opponent. The division moves on without him. It always does.

And Yoka — The Forgotten Victim

Tony Yoka is the one everyone forgets in these stories. He's a 2016 Olympic gold medallist at super heavyweight, he's fighting in front of a home French crowd at the Adidas Arena, he's finally landed a fight that matters, and it's been pulled from under him because his opponent's sample came back funny. He had a camp. He made the weight. He turned up. And now he's got nothing. That's the bit that should sting about this story. Drug cheats — proven or otherwise — cost their opponents money, reputation, and a chance to fight on their night. That's the real damage. Whoever ends up as the final finding on Okolie's test, the fighter that got hurt most today is the one who did nothing wrong.

The Prediction — What Happens Next

Right, here's my call. Okolie gets a provisional suspension this week. He'll fight the finding through legal channels, the investigation will drag into the autumn, and the best-case scenario for him is a reduced ban that keeps him out until early 2027. Worst case is four years and a career effectively finished at 33. You don't come back from a four-year layoff as a heavyweight contender. Yoka will end up on someone else's card in the summer. The French market wants him active. Queensberry or Samake promotions will find him a keep-busy fight in Paris by June or July. Adeleye, Hrgovic, even a rematch with a name-level American — all options. And the WBC? They'll name a new mandatory for Usyk's belt inside a month. That's how the sport works. The caravan moves. Final word: if Okolie's explanation is true, he'll prove it. The evidence is either there or it isn't. Until then, he's a fighter with a failed test and a cancelled fight, and the rest of the division is sprinting past him.